SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

which wirelessly transmits the data to a receiver or compatible smart device. This means that, for the most part, there's no need for frequent finger sticking. However, some CGM models require a ...

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former ...

The 2025 Advanced Technologies & Treatments for Diabetes (ATTD) conference took place in Amsterdam, Netherlands, bringing ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments.

Medicare Part B can cover a continuous glucose monitor (CGM), which offers a less invasive way of monitoring your blood sugar.

A real-world analysis showed a link between continuous glucose monitor (CGM) distribution channel and outcomes for patients with diabetes.

The Diabetic Care Devices Market is projected to grow from $16.6 billion in 2024 to $26.8 billion by 2029, at a CAGR of 10.1%. This report provides a comprehensive analysis of diabetes monitoring ...